Growth Metrics

Gyre Therapeutics (GYRE) Return on Capital Employed Growth (3y) (2014 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROCE Growth (3y) (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn - -
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn - -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn -
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn - -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn - -
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn -494.00
7 Evaxion A 62.56 Bn 62.54 Bn - -
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn -649.00
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn 4,853.00
10 Gyre Therapeutics 532.38 Mn 518.25 Mn 8.38 Mn -7,403.00

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 -7,403.00
Dec 31, 2025 -1,806.00
Sep 30, 2025 -1,184.00
Jun 30, 2025 2,267.00
Mar 31, 2025 24,003.00
Dec 31, 2024 18,132.00
Sep 30, 2024 4,828.00
Jun 30, 2024 1,764.00
Mar 31, 2024 1,459.00
Dec 31, 2023 -8,853.00
Sep 30, 2023 7,270.00
Jun 30, 2023 -7,716.00
Mar 31, 2023 11,837.00
Dec 31, 2022 10,659.00
Sep 30, 2022 8,343.00
Jun 30, 2022 3,489.00
Mar 31, 2022 -19,290.00
Dec 31, 2021 -13,885.00
Sep 30, 2021 -9,753.00
Jun 30, 2021 -6,330.00
Mar 31, 2021 -5,346.00
Dec 31, 2020 1,027.00
Sep 30, 2020 2,510.00
Jun 30, 2020 3,603.00
Mar 31, 2020 5,878.00
Dec 31, 2019 279.00
Sep 30, 2019 2,566.00
Jun 30, 2019 2,009.00
Mar 31, 2019 1,006.00
Dec 31, 2018 1,309.00
Sep 30, 2018 86.00
Jun 30, 2018 -972.00
Mar 31, 2018 -1,013.00
Dec 31, 2017 -6,422.00
Sep 30, 2017 -6,090.00
Jun 30, 2017 -5,892.00
Mar 31, 2017 -7,773.00
Dec 31, 2016 -5,570.00
Sep 30, 2016 -5,567.00
Jun 30, 2016 -4,270.00
Mar 31, 2016 -3,718.00
Dec 31, 2015 -3,589.00
Sep 30, 2015 -2,084.00
Jun 30, 2015 -690.00
Mar 31, 2015 -675.00
Dec 31, 2014 -800.00
Sep 30, 2014 -1,575.00